Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12 USD | -6.18% | +12.68% | +96.08% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 418K | Sales 2025 * | 19.8M | Capitalization | 311M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -100M | EV / Sales 2024 * | 744 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 15.7 x |
P/E ratio 2024 * |
-2.79
x | P/E ratio 2025 * |
-3.98
x | Employees | 122 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.53% |
Latest transcript on Inovio Pharmaceuticals, Inc.
1 day | -6.18% | ||
1 week | +12.68% | ||
Current month | +4.80% | ||
1 month | +17.65% | ||
3 months | +51.32% | ||
6 months | +133.05% | ||
Current year | +96.08% |
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 19-03-24 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 02-05-31 |
Chief Tech/Sci/R&D Officer | - | 07-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 03-11-30 |
Lota Zoth
BRD | Director/Board Member | 64 | 17-12-31 |
Jay Shepard
BRD | Director/Board Member | 65 | 20-01-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +9.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 12 | -6.18% | 414,844 |
24-05-16 | 12.79 | -2.14% | 366,100 |
24-05-15 | 13.07 | +14.45% | 731,790 |
24-05-14 | 11.42 | +0.53% | 410,955 |
24-05-13 | 11.36 | +6.67% | 342,374 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.08% | 311M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- INO Stock